Sterile Injectable Pharma Plant for Sale in Baddi –[WHO-GMP Certified]

Plot Size

40000 Sq. Ft.

Building Size

60000 Sq. Ft.

Asking Price

INR 50 crore

Available

For Sale

Certification

WHO-GMP

Company Details

Plant listing · Baddi, Himachal Pradesh

Sterile Injectable Pharma Plant for Sale in Baddi

A WHO-GMP-certified sterile manufacturing facility in Baddi, District Solan, licensed for liquid vials, ampoules, dry powder injections and ophthalmic preparations.

40,000Plot size · sq. ft.
60,000Building size · sq. ft.
INR 50 croreAsking price
150,000Units / 8 hours

At a glance

Facility overview

The plant was established in 2005, with construction started in February 2004. It has a sterile general section and a Beta section, and operates six days per week from 9:00 AM to 5:30 PM.

ParameterDetails
LocationBaddi, District Solan, Himachal Pradesh
CertificationsWHO-GMP, GMP, GLP, ISO Certified
Licensed forSVP (Liquid Vials, Ampoules), Dry Powder Injections, Ophthalmic Preparations
Facility typeSterile General + Beta Section
Built-up area15,000 sq. ft. × 4 floors
ManpowerMore than 100 trained employees

Licensed scope

Injectable and ophthalmic manufacturing

Dosage forms

  • Small Volume Parenterals (SVP): liquid vials, ampoules and dry powder injections
  • Sterile ophthalmic preparations
  • Beta Lactam injectables: dry powder

Licensing and export status

The company is licensed by the Food and Drugs Control Administration, Himachal Pradesh, under Form 25 & 28. It is described as export-ready with neutral codes HP/Drugs/MNB/****** and HP/Drugs/1VB/******.

Quality systems

cGMP operations and validation

Quality management system

Documented controls

Quality processes are presented against CDSCO expectations and the facility’s stated WHO-GMP and GLP practices.

  • Written SOPs and protocols
  • Self-inspections twice a year
  • Batch record reviews
  • Vendor audits and qualified vendor list
  • Complaint handling and product recall system
  • Training programs for technical personnel

Validation and calibration

Planned, recorded processes

For a broader readiness review, see Laafon’s CDSCO Schedule-M Compliance Dashboard.

  • Validation Master Plan for facility and process validations
  • Area, process, cleaning, equipment and analytical validations
  • Routine revalidation under change control
  • External and internal calibration logs for balances, thermometers and pressure gauges
  • Daily manufacturing records updated digitally
“Innovation and Quality Culture, Customer Satisfaction, Employee Empowerment through cGMP and GLP.”

Infrastructure and utilities

Sterile production support systems

Air handling and hygiene

  • 23 AHUs, including 12 dedicated to the Beta Section
  • HEPA terminal filters rated at 0.3 micron
  • RH control: NMT 25% in dry areas; NMT 55% in non-critical areas
  • 60+ air changes per hour
  • Separate male and female GMP-compliant gowning areas, lint-free garments and photo-guided gowning and hand-washing SOPs
  • Yearly medical checkups and vision tests for visual inspection personnel

Water, effluent and equipment

  • Purified Water and WFI: fully looped, validated, 24/7 recirculating loop; WFI at NLT 80°C
  • Stainless steel tanks; dead leg ratio below 1.5× ID
  • RO + distillation system with validated sampling protocols
  • ETP: 88 KL/day trade effluent + 25 KL/day non-trade; stated CPCB compliance
  • SS316L contact parts, PLC batch handling, microprocessor-based manufacturing, and digital inventory and lab systems

Buyer context

A ready-operating plant in the Baddi pharma hub

This listing may suit third-party manufacturers, expanding PCD brands and buyers seeking an export-ready sterile manufacturing setup in Baddi. Production, warehouse, QC and utility areas are stated to be categorized to WHO-GMP norms, with cleaning SOPs, checklists and preventive maintenance records maintained to FDA audit expectations.

Similar new setup estimateINR 35 croreSeller-stated comparison for similar machinery and sections.
Estimated establishment period3 yearsIndicative time cited for a similar new facility.
Seller-stated monthly sales₹6 crore+Subject to financial, customer and operational verification.

Important: The INR 35 crore / 3-year comparison and ₹6 crore+ monthly sales are seller-provided figures. They are not an independent valuation, forecast, legal opinion or financial advice. Verify licences, inspection history, machinery, financials, customer base, capacity and all regulatory claims through due diligence before any commitment.

For a separate planning estimate, use the Pharma Plant Setup Cost Calculator. You can also review other pharma plants for sale on Laafon.

FAQs

Questions buyers commonly ask

Liquid injections, dry powder injections, ampoules and ophthalmic preparations.
The listing states that it holds a neutral code and WHO-GMP certification and is export-ready. Buyers should independently confirm market-specific registration and export requirements.
Yes. Separate areas and AHUs are maintained for the Beta Lactam section.
Around 100 trained employees are working across departments; the facility highlights list more than 100 trained employees.
The listing estimates around INR 35 crore and three years for a similar machinery-and-sections setup. Actual cost and timing can differ materially.

Darshan Singh

Founder, Laafon Galaxy Pharmaceuticals · 23 years in pharmaceutical QA/QC & drug regulatory affairs.

Request financials, machinery list or a site visit

Contact Laafon for the brochure and listing details. Site verification and professional due diligence are recommended.

Listing information, capacities, certifications, availability and commercial figures are supplied for enquiry purposes and should be independently verified. This content is not legal, regulatory, investment or financial advice.

Production Capacity: 150000 units /8 hours
Contact Regarding the Company:
Share on Social Media
Company Images
Sterile injectable pharma plant for sale in Baddi — WHO-GMP filling line
Injectable Pharma Plant for Sale in Baddi